Strategy & Speed of Execution
Digital health startups can take too long to find their product-market fit, which hurts their financial runway.
JC Muyl
As a C-Suite Executive, JC scaled multiple digital health startups towards successful exits, including C3i, which he grew from 20 people in NYC to 1,500 employees globally.
Today, JC advises healthcare organizations with their digital health product strategy, including adding Generative AI features.
As a product strategist, clients leverage JC’s broad knowledge of multiple segments of healthcare to find more potential use cases for their digital health products.
JC operates in Life Sciences, Payers, Employers, Providers, Labs, Clinical Trials, Behavioral Health, Diabetes, Patient Advocacy, Orphan Drugs, Med Devices and more.
As a fractional executive, JC brings hands-on experience managing multiple functions as a member of the C-Suite. His clients use this experience to scale their management team at a fraction of the cost.
On a personal level, JC is an active volunteer for mental and physical disability causes (Best Buddies, Paralyzed Veterans of America) and founded MyRareData, a non-profit that helps rare disease groups leverage digital health.
Clients We Serve
We help Digital Health CEOs extend their financial runway
We help investors augment the C-suite of their portfolio companies at a fraction of the cost